EOJOAM
VERA icon

E. Ohman J:or Asset Management’s Vera Therapeutics VERA Stock Holding History

E. Ohman J:or Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Buy
85,777
+42,787
+100% +$1.59M 0.09% 123
2026
Q1 		$1.73M Buy
42,990
+3,490
+9% +$150K 0.05% 200
2025
Q4 		$2M Buy
+39,500
New +$1.4M 0.05% 188

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

E. Ohman J:or Asset Management's VERA Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Vera Therapeutics (VERA) stake by 100% in Q2 2026, buying an estimated $1.59M and bringing the position to 85,777 shares worth $3.68M. The position accounts for 0.09% of the portfolio, ranked #123.

E. Ohman J:or Asset Management first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • E. Ohman J:or Asset Management held 85,777 shares of Vera Therapeutics worth $3.68M as of Q2 2026.
  • E. Ohman J:or Asset Management bought 42,787 Vera Therapeutics shares in Q2 2026, an estimated $1.59M.
  • Vera Therapeutics made up 0.09% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #123 holding.
  • E. Ohman J:or Asset Management first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.